Can low-dose radiotherapy reshape osteoarthritis care after Siemens Healthineers’ FDA clearance
Siemens Healthineers expands TrueBeam into osteoarthritis care with FDA clearance. Find out how radiotherapy could reshape chronic pain treatment.
AptarGroup enters Phase II POSITS study as delivery partner for ENA Respiratory’s INNA-051 nasal spray
Aptar’s UDS Powder system enters ENA Respiratory’s POSITS Phase II trial. Analyse what INNA-051 must prove in 2026 and why the device choice matters. Read more.
Curi Bio and Battelle commercialise human NMJ assay as GLP-ready alternative to mouse bioassay for botulinum toxin testing
Curi Bio and Battelle partner to commercialise a human NMJ assay for botulinum toxin potency testing. What this changes for NAM adoption and the mouse bioassay. Read more.
Can Cleerly’s AI platform replace invasive IVUS? INVICTUS registry data suggest noninvasive parity
Cleerly’s INVICTUS registry shows AI-QCT matches IVUS in coronary plaque quantification. Read the clinical analysis.
How Exact Sciences is building a multi-platform cancer diagnostics case at AACR 2026
Exact Sciences presents Oncodetect MRD and Cancerguard MCED data at AACR 2026. Analysis of what the new TNBC and multi-biomarker classifier findings mean for clinical adoption.
Fulgent Genetics acquires Bako Diagnostics and StrataDx to offset precision diagnostics headwind
Fulgent Genetics closes $56.9M Bako and StrataDx acquisition. What it means for anatomic pathology growth, margin risk, and diagnostic consolidation in 2026.
How Alamar Biosciences’ Neuro 220 Panel could reshape biomarker discovery in Alzheimer’s and Parkinson’s research
Discover how Alamar Biosciences’ Neuro 220 Panel could transform CNS biomarker research and accelerate diagnostics and trials.
Guardant Health brings Shield multi-cancer detection test to Asia through Manulife insurer deal
Guardant Health partners with Manulife to launch its Shield MCD blood test in Hong Kong, Singapore and the Philippines. Analysis of what this means for oncology.
Johnson & Johnson expands pulsed field ablation footprint as VARIPULSE reaches Peru electrophysiology centers
Johnson & Johnson launches VARIPULSE pulsed field ablation technology in Peru. Discover what this means for atrial fibrillation treatment and electrophysiology innovation.
Why Convatec is expanding its ESENTA platform with the eakin freeseal ostomy seal partnership
Convatec and Eakin Healthcare launch the eakin freeseal ostomy seal in the U.S. Discover what this means for leakage prevention and the evolving ostomy care market.